Open original FDA record ↗Recall record
- FDA identifier
- Z-3047-2026
- Company in FDA record
- Diagnostica Stago, Inc.
- FDA classification date
- Aug 28, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified
Source facts
- Action
- Diagnostica Stago issued an URGENT: MEDICAL DEVICE RECALL (REMOVAL) notice to its consignees on 7/29/2026 via email. The notice described the issue, risk assessment, and requested the following: "Actions Required To prevent potential workflow disruptions associated with the increased recalibration frequency, we request that you: " Immediately discontinue use of STA-Staclot Protein S, Lot 273074. " Dispose of any remaining inventory of the affected lot in accordance with your facility's procedures and local regulations. " Complete, sign, and return the enclosed Acknowledgement Form by email to confirm receipt and understanding of this notification. Stago will provide a credit for the destroyed kits you indicate on the Acknowledgement Form." For questions regarding this notice or require assistance, please contact Stago's 24/7 Hotline at 1-800-725-0607.
- Initiated
- 2026-07-29
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR.
- Recall number
- Z-3047-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221774
- FDA classified
- 2026-08-28
- Recall event number
- 99531